Clinical Trials Directory

Trials / Unknown

UnknownNCT05705960

Chestnut Consumption on Modulation of Gut Microbiota and Metabolic Parameters

The Effect of Chestnut Consumption on Modulation of Gut Microbiota and Metabolic Parameters

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
33 (estimated)
Sponsor
Universidade Nova de Lisboa · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The chestnut tree (Castanea sativa Mill.) is a species widely cultivated in Portugal, which is a major producer of chestnuts. Nuts are nutritionally interesting, not only because of their content of vitamins, minerals, and phytochemicals but also of their high fiber content. Fiber, as it is not digested by humans, has a preponderant role in the intestinal microbiota, for its maintenance, and, consequently, has an impact on metabolic status. The inclusion of foods rich in these components, and with extensive local production, can be an excellent strategy for improving the metabolic parameters of the population. The main objective of this single group assignment clinical trial is to evaluate the effect of including roasted chestnuts in the daily diet on the composition and diversity of the intestinal microbiota. It is also intended to evaluate metabolic parameters to determine the impact of this intervention.

Conditions

Interventions

TypeNameDescription
OTHERChestnutDaily consumption of roasted chestnut (150g) for 14 days

Timeline

Start date
2022-11-15
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2023-01-31
Last updated
2023-01-31

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT05705960. Inclusion in this directory is not an endorsement.